The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial

BMJ Open
Andrew M WilsonLindi Staunton

Abstract

Pulmonary rehabilitation (PR) provides benefit for patients with chronic obstructive pulmonary disease (COPD) in terms of quality of life (QoL) and exercise capacity; however, the effects diminish over time. Our aim was to evaluate a maintenance programme for patients who had completed PR. Primary and secondary care PR programmes in Norfolk. 148 patients with COPD who had completed at least 60% of a standard PR programme were randomised and data are available for 110 patients. Patients had greater than 20 pack year smoking history and less than 80% predicted forced expiratory volume in 1 s but no other significant disease or recent respiratory tract infection. Patients were randomised to receive a maintenance programme or standard care. The maintenance programme consisted of 2 h (1 h individually tailored exercise training and 1 h education programme) every 3 months for 1 year. The Chronic Respiratory Questionnaire (CRQ) (primary outcome), endurance shuttle walk test (ESWT), EuroQol (EQ5D), hospital anxiety and depression score (HADS), body mass index (BMI), body fat, activity levels (overall score and activity diary) and exacerbations were assessed before and after 12 months. There was no statistically significant difference b...Continue Reading

Associated Clinical Trials

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Nov 1, 1996·Journal of Clinical Epidemiology·D A RedelmeierR S Goldstein
Dec 31, 2002·American Journal of Respiratory and Critical Care Medicine·Andrew L RiesLela M Prewitt
Apr 23, 2003·The Practitioner·Eric Livingston, Neil C Thomson
Oct 3, 2003·Lancet·P M A Calverley, Paul Walker
Mar 24, 2006·Respiratory Medicine·Elisabeth ArnoldCaroline Ellis-Hill
Apr 26, 2006·Respiration; International Review of Thoracic Diseases·Micaela RomagnoliEnrico M Clini
Feb 3, 2007·Archives of Physical Medicine and Rehabilitation·Brenda O'NeillJoseph McMahon
Aug 2, 2007·Journal of Cardiopulmonary Rehabilitation and Prevention·Andrew L Ries
Sep 4, 2007·Lancet·David M Mannino, A Sonia Buist
Jun 29, 2010·BMJ : British Medical Journal·John O'ReillyUNKNOWN Guideline Development Group
Jul 17, 2012·Respiratory Medicine·Marilyn L MoyCaroline R Richardson
Oct 18, 2012·Journal of Pain and Symptom Management·Huong Q NguyenVirginia Carrieri-Kohlman
Aug 2, 2013·Thorax·Charlotte E BoltonUNKNOWN British Thoracic Society Standards of Care Committee
Jan 17, 2014·Chronic Respiratory Disease·Laura DesveauxDina Brooks
Sep 5, 2014·The European Respiratory Journal·Benoit BorelFrançois Maltais

❮ Previous
Next ❯

Citations

Mar 25, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jennifer A AlisonUNKNOWN Lung Foundation Australia and the Thoracic Society of Australia and New Zealand
Mar 21, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Lissa M Spencer, Zoe J McKeough
Apr 17, 2020·The Cochrane Database of Systematic Reviews·Angela T BurgeAnne E Holland
Aug 31, 2021·Physiotherapy Canada. Physiothérapie Canada·Pamela TanguayNicole Marquis
Jul 31, 2021·Annals of Physical and Rehabilitation Medicine·Sara Souto-MirandaAlda Marques

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.